» Articles » PMID: 24651460

Comparative Molecular Dynamics Simulations of Mitogen-activated Protein Kinase-activated Protein Kinase 5

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2014 Mar 22
PMID 24651460
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

The mitogen-activated protein kinase-activated protein kinase MK5 is a substrate of the mitogen-activated protein kinases p38, ERK3 and ERK4. Cell culture and animal studies have demonstrated that MK5 is involved in tumour suppression and promotion, embryogenesis, anxiety, cell motility and cell cycle regulation. In the present study, homology models of MK5 were used for molecular dynamics (MD) simulations of: (1) MK5 alone; (2) MK5 in complex with an inhibitor; and (3) MK5 in complex with the interaction partner p38α. The calculations showed that the inhibitor occupied the active site and disrupted the intramolecular network of amino acids. However, intramolecular interactions consistent with an inactive protein kinase fold were not formed. MD with p38α showed that not only the p38 docking region, but also amino acids in the activation segment, αH helix, P-loop, regulatory phosphorylation region and the C-terminal of MK5 may be involved in forming a very stable MK5-p38α complex, and that p38α binding decreases the residual fluctuation of the MK5 model. Electrostatic Potential Surface (EPS) calculations of MK5 and p38α showed that electrostatic interactions are important for recognition and binding.

Citing Articles

Structure-guided computational insecticide discovery targeting -N-acetyl-D-hexosaminidase of .

Tahir A, Siddiqi A, Maryam A, Vedithi S, Blundell T J Biomol Struct Dyn. 2023; 42(21):11717-11730.

PMID: 37814544 PMC: 11573315. DOI: 10.1080/07391102.2023.2264394.


The functional regulatory details of ERK2 in complex with RSK1: an insight.

Jafari S, Mohamadi Farsani F, Ganji M, Ganjalikhany M RSC Adv. 2022; 11(19):11048-11056.

PMID: 35423626 PMC: 8695832. DOI: 10.1039/d1ra01020d.

References
1.
Seternes O, Mikalsen T, Johansen B, Michaelsen E, Armstrong C, Morrice N . Activation of MK5/PRAK by the atypical MAP kinase ERK3 defines a novel signal transduction pathway. EMBO J. 2004; 23(24):4780-91. PMC: 535098. DOI: 10.1038/sj.emboj.7600489. View

2.
Underwood K, Parris K, Federico E, Mosyak L, Czerwinski R, Shane T . Catalytically active MAP KAP kinase 2 structures in complex with staurosporine and ADP reveal differences with the autoinhibited enzyme. Structure. 2003; 11(6):627-36. DOI: 10.1016/s0969-2126(03)00092-3. View

3.
Schumacher S, Laass K, Kant S, Shi Y, Visel A, Gruber A . Scaffolding by ERK3 regulates MK5 in development. EMBO J. 2004; 23(24):4770-9. PMC: 535084. DOI: 10.1038/sj.emboj.7600467. View

4.
Brand F, Schumacher S, Kant S, Menon M, Simon R, Turgeon B . The extracellular signal-regulated kinase 3 (mitogen-activated protein kinase 6 [MAPK6])-MAPK-activated protein kinase 5 signaling complex regulates septin function and dendrite morphology. Mol Cell Biol. 2012; 32(13):2467-78. PMC: 3434500. DOI: 10.1128/MCB.06633-11. View

5.
Gaestel M . MAPKAP kinases - MKs - two's company, three's a crowd. Nat Rev Mol Cell Biol. 2006; 7(2):120-30. DOI: 10.1038/nrm1834. View